Breaking News, Promotions & Moves

Element Biosciences Appoints Chief Commercial Officer

Dr. Aitkenhead brings 20 years of international commercial experience in the clinical and life science research industry.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Element Biosciences Inc., developer of the Element AVITI System, a new and disruptive DNA sequencing platform, has appointed Mark Aitkenhead, PhD, as Chief Commercial Officer. In this role, Dr. Aitkenhead will build, guide and manage the customer-facing functions of the company, including sales, marketing, customer support and training. As a member of the executive leadership team, he will also develop and implement strategies for driving adoption of current and future products in the marketplac...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters